TY  - GEN
AU  - Kreutzer,T C
AU  - Alge,C S
AU  - Wolf,A H
AU  - Kook,D
AU  - Burger,J
AU  - Strauss,R
AU  - Kunze,C
AU  - Haritoglou,C
AU  - Kampik,A
AU  - Priglinger,S
TI  - Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion
SN  - 1468-2079
PY  - 2008///0314
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Angiogenesis Inhibitors
KW  - administration & dosage
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - Bevacizumab
KW  - Drug Administration Schedule
KW  - Female
KW  - Fovea Centralis
KW  - pathology
KW  - Humans
KW  - Injections
KW  - Macular Edema
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Retinal Vein Occlusion
KW  - complications
KW  - Treatment Outcome
KW  - Vascular Endothelial Growth Factor A
KW  - antagonists & inhibitors
KW  - Visual Acuity
KW  - drug effects
KW  - Vitreous Body
N1  - Publication Type: Clinical Trial; Journal Article
UR  - https://doi.org/10.1136/bjo.2007.123513
ER  -